A number of recent articles stated that the governments new reverse mortgage changes (Mortgagee Letter 2017-12) will make the program less attractive to borrowers. However, this might have been an initial overreaction. While the program is being adjusted, the changes to the program could improve the market, lower costs for some borrowers, and secure the long-term health of the program.
Investors in NetEase (NASDAQ:NTES) have generally seen their company benefit from a strong environment in the Chinese video game industry. Impressive growth in revenue and profits in past years helped fuel impressive gains for NetEase shares, and the appetite for more from consumers in China and elsewhere has seemed insatiable. Yet in every growth stock’s experience, a company eventually starts....More>>>
It’s been interesting to see the comments on Seeking Alpha made in reaction to the early round of 1Q17 results from U.S. banks. We’ve certainly got a market with forecasts of recession mingling with optimism that the Trump trade will re-emerge once the great man has done whatever he has to do in the meantime.
One theme we’ve seen, exemplified by JPMorgan (NYSE:JPM), is buoyant....More>>>
As we all know, stock valuations reflect the prevailing economic weather and corporate-profit forecast. Sunny conditions give investors confidence to buy, which generally means expensive stock prices. Right now, the S&P 500 is trading at 17.0 times expected earnings, almost 20% above the 10-year average of 14.3. Some highfliers have ascended to nosebleed levels, notably names like Netflix (Nasdaq:....More>>>
CGI (TSE:GIB.A) (NYSE:GIB) had its target price raised by stock analysts at Barclays from C$83.00 to C$89.00 in a report issued on Thursday. Barclays’ price objective points to a potential upside of 7.04% from the stock’s previous close.
Twitter is a great way to stay on top of tax news, tax information, and tax policy all over the world. You can instantly share links and pictures or simply lurk and watch your feed (though it's certainly more fun when you engage). Think of it like a virtual cocktail party: you can network and exchan
CGI Group (NYSE: GIB) and Information Services Group (NASDAQ:III) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and ins
OpGen (NASDAQ: OPGN) and Cancer Genetics (NASDAQ:CGIX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, profitability and ris
With three product candidates in the pipeline, at a very early stage, Scholar Rock will need a long time to see the FDA approving them. That said, the company has many patents, a licence with Janssen Biotech, and a fantastic team of professionals. While the risk may be too high for the individua